ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,382.25
-0.39%
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs Yen
157.479
0.05%
Brent Oil
81.925
-0.24%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. USOTC
  6. Biostar Pharmaceuticals Inc (CE) (BSPM)

  7. Biostar Pharmaceuticals Inc (CE) (BSPM) ニュース

BSPM

Biostar Pharmaceuticals (CE) (BSPM)

Biostar Pharmaceuticals Inc (CE)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:USOTC:BSPM
日付受信時刻ニュースソース見出しコード企業名
2019/01/0900 : 16Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
2018/08/2422 : 05Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
2018/08/2321 : 51GlobeNewswire Inc.Biostar Pharmaceuticals Announces Receipt of Additional Delisting Determination Letter from NasdaqUSOTC:BSPMBiostar Pharmaceuticals Inc (CE)
2018/07/2605 : 34Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
2018/07/0705 : 32Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
2018/07/0306 : 26Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
2018/05/3105 : 02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
2018/05/1705 : 12Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
2018/04/2405 : 02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
2018/04/0305 : 02Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
2018/02/0306 : 53Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
2018/02/0306 : 38Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
2018/02/0206 : 05Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
2017/12/2906 : 31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
2017/12/1906 : 31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
2017/12/0506 : 31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
2017/11/2106 : 11Edgar (US Regulatory)Quarterly Report (10-q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
2017/11/1607 : 02Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
2017/11/1606 : 34Edgar (US Regulatory)Quarterly Report (10-q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
2017/08/2905 : 01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
2017/08/1522 : 01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
2017/06/1306 : 16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
2017/05/2005 : 24Edgar (US Regulatory)Quarterly Report (10-q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
2017/05/1606 : 01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
2017/04/2205 : 17Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
2017/04/1405 : 05Edgar (US Regulatory)Annual Report (10-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
2017/04/0405 : 02Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
2017/02/2506 : 32Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
2017/02/1006 : 33Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
2017/01/2020 : 02Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:BSPM

最近閲覧した銘柄

AMEX
XLV
Health Care Select Sector
COIN
BTCUSD
Bitcoin
NYSE
KO
Coca Cola
NYSE
BAC
Bank of America
NASDAQ
NVDA
NVIDIA
SPI
SP500
S&P 500
NYSE
VZ
Verizon Communications
NASDAQ
MSFT
Microsoft
CCOM
US30
US 30
PM
XAUUSD
Gold vs US Dollar
USOTC
ADDYY
Adidas (QX)
USI
USTECH100
US Tech 100
AMEX
SPY
SPDR S&P 500
NASDAQ
AAPL
Apple
FX
USDGBP
US Dollar vs Sterling
NYSE
DIS
Walt Disney
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有